GNNSF
Price
$2.12
Change
+$0.45 (+26.95%)
Updated
Jul 18 closing price
Capitalization
4.67B
SILO
Price
$0.63
Change
-$0.00 (-0.00%)
Updated
Jul 18 closing price
Capitalization
4.51M
45 days until earnings call
Interact to see
Advertisement

GNNSF vs SILO

Header iconGNNSF vs SILO Comparison
Open Charts GNNSF vs SILOBanner chart's image
Genscript Biotech
Price$2.12
Change+$0.45 (+26.95%)
Volume$2.69K
Capitalization4.67B
Silo Pharma
Price$0.63
Change-$0.00 (-0.00%)
Volume$230.51K
Capitalization4.51M
GNNSF vs SILO Comparison Chart in %
Loading...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SILO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNNSF vs. SILO commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNNSF is a Hold and SILO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 20, 2025
Stock price -- (GNNSF: $2.12 vs. SILO: $0.63)
Brand notoriety: GNNSF and SILO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNNSF: 359% vs. SILO: 17%
Market capitalization -- GNNSF: $4.67B vs. SILO: $4.51M
GNNSF [@Biotechnology] is valued at $4.67B. SILO’s [@Biotechnology] market capitalization is $4.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNNSF’s FA Score shows that 0 FA rating(s) are green whileSILO’s FA Score has 0 green FA rating(s).

  • GNNSF’s FA Score: 0 green, 5 red.
  • SILO’s FA Score: 0 green, 5 red.
According to our system of comparison, GNNSF is a better buy in the long-term than SILO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNNSF’s TA Score shows that 5 TA indicator(s) are bullish while SILO’s TA Score has 6 bullish TA indicator(s).

  • GNNSF’s TA Score: 5 bullish, 2 bearish.
  • SILO’s TA Score: 6 bullish, 0 bearish.
According to our system of comparison, SILO is a better buy in the short-term than GNNSF.

Price Growth

GNNSF (@Biotechnology) experienced а +26.95% price change this week, while SILO (@Biotechnology) price change was +7.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

SILO is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNNSF($4.67B) has a higher market cap than SILO($4.51M). GNNSF YTD gains are higher at: 66.929 vs. SILO (-29.719).
GNNSFSILOGNNSF / SILO
Capitalization4.67B4.51M103,527%
EBITDAN/A-4.61M-
Gain YTD66.929-29.719-225%
P/E RatioN/AN/A-
RevenueN/A72.1K-
Total CashN/A5.45M-
Total DebtN/A18.9K-
FUNDAMENTALS RATINGS
GNNSF vs SILO: Fundamental Ratings
GNNSF
SILO
OUTLOOK RATING
1..100
5021
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
3965
P/E GROWTH RATING
1..100
42100
SEASONALITY SCORE
1..100
3875

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SILO's Valuation (62) in the null industry is in the same range as GNNSF (93). This means that SILO’s stock grew similarly to GNNSF’s over the last 12 months.

SILO's Profit vs Risk Rating (100) in the null industry is in the same range as GNNSF (100). This means that SILO’s stock grew similarly to GNNSF’s over the last 12 months.

GNNSF's SMR Rating (97) in the null industry is in the same range as SILO (98). This means that GNNSF’s stock grew similarly to SILO’s over the last 12 months.

GNNSF's Price Growth Rating (39) in the null industry is in the same range as SILO (65). This means that GNNSF’s stock grew similarly to SILO’s over the last 12 months.

GNNSF's P/E Growth Rating (42) in the null industry is somewhat better than the same rating for SILO (100). This means that GNNSF’s stock grew somewhat faster than SILO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNNSFSILO
RSI
ODDS (%)
Bullish Trend 3 days ago
63%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
64%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SILO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRAX0.960.04
+4.41%
Virax Biolabs Group Limited
QETA11.120.25
+2.30%
Quetta Acquisition Corp
NI40.22N/A
N/A
NiSource
PPBI22.10-0.01
-0.05%
Pacific Premier Bancorp
DJCO399.15-6.45
-1.59%
Daily Journal Corp

GNNSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNNSF has been loosely correlated with SILO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GNNSF jumps, then SILO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNNSF
1D Price
Change %
GNNSF100%
+26.95%
SILO - GNNSF
42%
Loosely correlated
-1.03%
SCNI - GNNSF
26%
Poorly correlated
+0.31%
CORT - GNNSF
25%
Poorly correlated
-3.06%
ORYZF - GNNSF
24%
Poorly correlated
N/A
ARGNF - GNNSF
23%
Poorly correlated
N/A
More

SILO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SILO has been loosely correlated with GNNSF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SILO jumps, then GNNSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SILO
1D Price
Change %
SILO100%
-1.03%
GNNSF - SILO
42%
Loosely correlated
+26.95%
VIR - SILO
30%
Poorly correlated
-1.46%
SANA - SILO
30%
Poorly correlated
+4.04%
CGEM - SILO
27%
Poorly correlated
-3.09%
CTMX - SILO
22%
Poorly correlated
+0.21%
More